Mnd - OmicsDI

Show results for

Unknown (451)
Genomics (21)
Proteomics (17)
Transcriptomics (8)
Metabolomics (4)

Organisms

Homo sapiens (13)
Schizophyllum commune H4-8 (12)
Mycobacterium tuberculosis SP7 (12)
Oryza sativa Japonica Group (12)
Candidatus Endoriftia persephonae (12)
Mycobacterium tuberculosis SP10 (12)
Mycobacterium tuberculosis SP13 (12)
Mycobacterium tuberculosis SP22 (12)
Enterobacter ludwigii (12)
Chlamydomonas reinhardtii (12)
Lama (12)
Pyricularia oryzae P131 (12)
Enterococcus mundtii CRL35 (12)
Oncorhynchus tshawytscha (12)
Pseudomonas canadensis (12)
Strongylocentrotus purpuratus (12)
Influenza A virus (A/California/04/2009(H1N1)) (12)
Homo (12)
Pseudomonas aeruginosa PAO1H2O (12)
Human alphaherpesvirus 1 strain 17 (12)
Quercus petraea (12)
Canis lupus (12)
Mycobacterium tuberculosis SP1 (12)
Marchantia polymorpha subsp. ruderalis (12)
Zymomonas mobilis subsp. mobilis ZM4 = ATCC 31821 (12)
Curtobacterium pusillum (12)
Methylocystis sp. (12)
Exiguobacterium sp. SH31 (12)
Palaemonetes sp. common grass shrimp associated circular virus (12)
Mus musculus (1)

Organisms

Homo sapiens (10)
Mus musculus (2)
Campylobacter jejuni subsp. jejuni NCTC 11168 = ATCC 700819 (1)

Repository

ENA (17)
pride (12)
geo (7)
MetaboLights (4)
biostudies-arrayexpress (3)
jPOST (3)
EGA (2)
MassIVE (2)

Tissue

Cell culture (6)
Brain (4)
Permanent cell line cell (3)
Striated muscle tissue (1)
Striated muscle cell (1)
Hematopoietic precursor cell (1)
Spinal column (1)
Neuronal stem cell (1)
Cerebral cortex (1)
Colon (1)

Disease

Amyotrophic lateral sclerosis (3)
Frontotemporal dementia (2)
Amyotrophic lateral sclerosis type 10 (1)
Hematopoietic system (1)
Motor neuron disease (1)
Duchenne muscular dystrophy (1)

Technology Type

Mass Spectrometry (12)
Shotgun proteomics (5)
Mass spectrometry assay (3)
Data-dependent acquisition (3)
Affinity purification coupled with mass spectrometry proteomics (3)
Gel-based experiment (2)
Bottom-up proteomics (2)
Mass spectrometry (1)
Affinity proteomics (1)
SWATH MS (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse-phase (3)
Liquid Chromatography MS - negative - reverse-phase (3)
ABCIEX TripleTOF 5600 (1)
Q Exactive Plus (1)
Q Exactive (1)

Publication Date

2025 (7)
2026 (6)
2021 (4)
2024 (4)
2010 (3)
2011 (2)
2020 (2)
2018 (1)
2022 (1)

CHEBI ID

CHEBI:62013 (1)
CHEBI:182915 (1)
CHEBI:133695 (1)
CHEBI:190990 (1)
CHEBI:166490 (1)
CHEBI:41189 (1)
CHEBI:86047 (1)
CHEBI:133747 (1)
CHEBI:141006 (1)
CHEBI:33885 (1)
CHEBI:37156 (1)
CHEBI:41183 (1)
CHEBI:17721 (1)
CHEBI:42600 (1)
CHEBI:44383 (1)
CHEBI:37655 (1)
CHEBI:133179 (1)
CHEBI:32159 (1)
CHEBI:37714 (1)
CHEBI:18040 (1)
CHEBI:32321 (1)
CHEBI:30779 (1)
CHEBI:17535 (1)
CHEBI:188102 (1)
CHEBI:53455 (1)
CHEBI:61302 (1)
CHEBI:39066 (1)
CHEBI:52330 (1)
CHEBI:58275 (1)
CHEBI:28664 (1)

Metabolite Name

Metab_20532 (2)
Metab_20424 (2)
Metab_20233 (2)
Metab_20214 (2)
Metab_20190 (2)
Metab_20166 (2)
Metab_20011 (2)
Metab_19993 (2)
Metab_19868 (2)
Metab_19800 (2)
Metab_19693 (2)
Metab_19660 (2)
Metab_19581 (2)
Metab_19447 (2)
Metab_19434 (2)
Metab_19370 (2)
Metab_19359 (2)
Metab_19357 (2)
Metab_19336 (2)
Metab_19283 (2)
Metab_19276 (2)
Metab_19272 (2)
Metab_19244 (2)
Metab_19238 (2)
Metab_19050 (2)
Metab_19023 (2)
Metab_18967 (2)
Metab_18946 (2)
Metab_18889 (2)
Metab_18870 (2)

First Public Date

2025 (3)
2023 (3)
2014 (3)
2021 (2)
2020 (2)
2026 (1)
2024 (1)
2022 (1)
2018 (1)

Classification

bacteria (1)

Study type

Transcription profiling by array (2)
Comparative genomic hybridization by array (1)

Release Date

2025 (58)
2022 (55)
2020 (52)
2024 (44)
2023 (37)
2021 (32)
2017 (31)
2018 (28)
2019 (26)
2015 (21)
2016 (17)
2014 (15)
2026 (7)
2013 (7)
2011 (6)
2008 (4)
2010 (3)
2005 (3)
2009 (2)
2007 (2)
2012 (1)
2006 (1)
2004 (1)
2000 (1)

Lab affiliation

Centre for MND Research, Department of Biomedical Sciences, Macquarie University, North Ryde, NSW Australia (1)
Centre for MND Research, Department of Biomedical Sciences, Macquarie University, North Ryde, NSW, 2109 Australia (1)
Motor Neuron Disease Research Centre, Macquarie Medical School, Faculty of Medicine, Health, and Human Sciences, Macquarie University, North Ryde, NSW, Australia. (1)
Department of Molecular and Cellular Hemostasis, Sanquin Research, Amsterdam, the Netherlands. (1)
Neurodegeneration Pathobiology Laboratory, Queensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia (1)
Florey Institute, University of Melbourne, Parkville, Victoria 3052, Australia (1)
Motor Neuron Disease Research Centre, Macquarie University, NSW, 2113, Australia (1)
UK Dementia Research Institute Department of Chemistry University of Cambridge, UK (1)
Centre for MND Research, Department of Biomedical Sciences, Faculty of Medicine, Health and Human Sciences, Macquarie University, North Ryde, NSW, 209, Australia (1)
Centre for MND Research, Macquarie Medical School, Faculty of Medicine Health and Human Sciences, Macquarie University, North Ryde NSW 2109 Australia (1)
Department of Reumotology, Allegy and immunology (1)
Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada (1)

Previous page
1 / 51
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 51
Next page

Sort by:

Relevance

Page size

Whole blood transcriptome profile identifies motor neurone disease (MND) RNA biomarker signatures

PRJNA1163403 | ENA

Charity financial support to motor neuron disease (MND) patients in Greater London: the impact of patients' socioeconomic status-a cross-sectional study.

Not available

S-EPMC6377508 | biostudies-literature

Whole blood transcriptome profile identifies motor neurone disease (MND) RNA biomarker signatures

(1) Background: Blood-based biomarkers for motor neuron disease are needed for better di-agnosis, progression prediction, and clinical trial monitoring. We used whole blood-derived total RNA and performed whole transcriptome analysis to compare the gene expression pro-files in (motor neurone disease...

ORGANISM(S): Homo sapiens

2025-01-29 | GSE277709 | GEO

When months matter; modelling the impact of the COVID-19 pandemic on the diagnostic pathway of Motor Neurone Disease (MND).

Not available

S-EPMC9882907 | biostudies-literature

Structural brain correlates of cognitive and behavioral impairment in MND.

Not available

S-EPMC6867462 | biostudies-literature

Statistical analysis plan for the motor neuron disease systematic multi-arm adaptive randomised trial (MND-SMART).

Not available

S-EPMC9843918 | biostudies-literature

Role of EphA4 in Mediating Motor Neuron Death in MND.

Not available

S-EPMC8430883 | biostudies-literature

Primary progressive aphasia and the FTD-MND spectrum disorders: clinical, pathological, and neuroimaging correlates.

Not available

S-EPMC6759325 | biostudies-literature

Targeting CD19 CAR-T With MND Promoter Enhances Tumour Killing.

Not available

S-EPMC12439678 | biostudies-literature

Protein-agnostic pulldown of brain-derived aggregates from Motor Neuron Disease

Characterisation of homognised BA tissue extracts from TDP-43 MND (Ã—5), SOD1-MND (Ã—2) and neurologically normal controls (Ã—3) using the protein-agnostic aggregate probe CAP1.

ORGANISM(S): Homo sapiens (Human)

2026-02-03 | PXD061429 | Pride

Previous page
1 / 51
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 51
Next page

Sort by:

Relevance

Page size

501 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Classification

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets